SEARCH · Search PubMed
Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Obtaining blood samples for antibiotic analysis from intravenous lines through which the antibiotic had been administered was critically evaluated. Flushing volumes required to remove contaminating antibiotic varied with the type of antibiotic and with different plastics. Obtaining blood specimens from the intravenous lines is not practical in infants and not advised in adults.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Blood probes obtained from the central-venous catheter are common methods on intensive care units. In the present paper, the conditions for obtaining blood samples for clotting analysis of patients with heparinized catheters are examined and compared to the literature. In these patients, blood samples were drawn simultaneously from central as well as peripher lines. The results of the examination were prospectively compared. After the aspiration of 10 ml blood from centralvenous catheters, there are no differences between peripher and central venous blood samples.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The reliability of the ESP Culture System II (ESP II; AccuMed International, Westlake, Ohio), a continuously monitoring, nonradiometric mycobacterial culture system, for recovery of mycobacteria from sediments of blood collected in an Isolator tube was evaluated by comparing its performance to inoculation of the sediment onto Middlebrook 7H11/7H11 selective biplates. Of 1,704 blood specimens, 73 (4.3%) were positive for mycobacteria (68 Mycobacterium avium complex and 5 M. tuberculosis). Fifty-three specimens were positive by both methods; 13 were positive by ESP II only, and 7 were positive by Middlebrook agar only (chi square = 1.8; P > 0.05). The mean times to positivity were 15.6 days for ESP II and 19.0 days for Middlebrook agar (P < 0.01). The time to detection was the same for 13 specimens; ESP II was positive first for 33, and agar plates were positive first for 7. ESP II allowed recovery of more mycobacteria (90.4% of all isolates versus 82.2% for Middlebrook agar) from sediments of blood specimens collected in Isolator tubes, and it provided significantly faster detection than did Middlebrook plates.
A simple method of collecting arterial blood in cattle by puncture of the arteria iliaca externa per rectum is described. Individual collections do not induce any local reaction nor do they impair the overall condition and milk yield of the animals.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
BACKGROUND: Matrix metalloproteinases (MMP) in blood are promising new diagnostic tools. It was shown that the blood sampling process resulted in different blood concentrations of MMPs. To clarify whether the sampling process also influences the diagnostic validity of MMPs, MMP-9 measurements were performed in plasma and serum samples of patients with prostate carcinoma and renal cell cancer. METHODS: MMP-9 ELISAs were performed in samples of heparin plasma and serum collected in blood tubes with and without clot accelerator. Measurements were undertaken in 78 healthy persons, 33 patients with prostate carcinoma and 33 patients with renal cell carcinoma. RESULTS: MMP-9 showed higher concentrations in serum samples than in heparin plasma and was about threefold higher in serum samples collected in tubes with clot activator than in native serum samples. Both patient groups had lower MMP-9 concentrations in serum, whereas in plasma, patients with renal cell carcinoma had higher, but patients with prostate cancer unchanged MMP-9 concentrations. 13 of 33 patients with renal cell carcinoma had increased MMP-9 plasma values but no patient had increased serum concentrations. CONCLUSIONS: To optimise the diagnostic validity of the MMP-9 in blood, measurements should be performed in heparin plasma but not in serum.